Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Loading
Home›
Research›
People›
Charles Homcy
AddedMar 31, 2024
UpdatedMay 31, 2026
Charles Homcy

Charles Homcy

Board Member, Cephalon

Crunchbase

Charles Homcy's Career

Cephalon
Cephalon

Malvern, PA, US

Board Member· Board
Pliant Therapeutics
Pliant Therapeutics

South San Francisco, CA, US

Board Member· Board
CytomX Therapeutics
CytomX Therapeutics

South San Francisco, CA, US

Board Member· Board
BridgeBio Pharma
BridgeBio Pharma

Palo Alto, CA, US

Board Member· Board
Faze Medicines
Faze Medicines

Cambridge, MA, US

Board Member· Board
Topica Pharmaceuticals
Topica Pharmaceuticals

Palo Alto, CA, US

Board Member· Board
Johns Hopkins University
Johns Hopkins University

Baltimore, MD, US

Board Member· Board
Maze Therapeutics
Maze Therapeutics

South San Francisco, CA, US

Board Member· Board

Create your profile now and gain access to exclusive deals and high-potential startups.

aVenture product preview
aVenture product preview
aVenture product preview

Charles Homcy's Career

Cephalon
Cephalon
Acquired01987Malvern, PA, US
Board Member· Board

Leadership at Cephalon

Vaughn KailianVaughn KailianBoard Member
William P Egan \"Bill\"William P Egan \"Bill\"Board Member
Kevin MoleyKevin MoleyBoard Member
Frank BaldinoFrank BaldinoFounder
Martyn GreenacreMartyn GreenacreBoard Member

Similar to Cephalon

NeuroTherapeutics PharmaNeuroTherapeutics PharmaChicago, IL, USPharmaceuticals, Therapeuticsest. 2006NeuroTherapeutics PharmaChicago, IL, US · est. 2006

NeuroTherapeutics Pharma: A US-based biopharmaceutical firm specializing in neuropathic and acute pain treatments.

Public · $60.7M30
TrevenaTrevenaKing of Prussia, PA, USPharmaceuticalsest. 2007TrevenaKing of Prussia, PA, US · est. 2007

Trevena: A biopharmaceutical firm innovating novel CNS disorder treatments.

Public · $473.7M35
Supernus PharmaceuticalsSupernus PharmaceuticalsRockville, MD, USPharmaceuticalsest. 2005Supernus PharmaceuticalsRockville, MD, US · est. 2005

US-based Supernus Pharmaceuticals develops and markets proprietary drugs for central nervous system disorders.

Public · $689.5M612
UCBUCBCity of Brussels, Flemish Brabant, BEPharmaceuticalsest. 1928UCBCity of Brussels, Flemish Brabant, BE · est. 1928

Belgium-based UCB SA is a global biopharmaceutical firm specializing in CNS disorders and inflammatory diseases.

Public · $195.3M7.6k
Pliant Therapeutics
Pliant Therapeutics
Public$694.9M1242015South San Francisco, CA, US
Board Member· Board

Leadership at Pliant Therapeutics

David PyottDavid PyottBoard Member
Hal ChapmanHal ChapmanBoard Member
Smital ShahSmital ShahBoard Member
Perry KarsenPerry KarsenBoard Member
Katharine KnobilKatharine KnobilBoard Member
Suzanne BruhnSuzanne BruhnBoard Member
CytomX Therapeutics
CytomX Therapeutics

South San Francisco, CA, US

Board Member· Board
BridgeBio Pharma
BridgeBio Pharma
Public$3.6B3922015Palo Alto, CA, US
Board Member· Board

Leadership at BridgeBio Pharma

Jennifer CookJennifer CookBoard Member
Richard SchellerRichard SchellerBoard Member
Jim MomtazeeJim MomtazeeBoard Member
Neil KumarNeil KumarFounder
Andrea EllisAndrea EllisBoard Member
Randy ScottRandy ScottBoard Member
Faze Medicines
Faze Medicines
Series A$81M402020Cambridge, MA, US
Board Member· Board

Leadership at Faze Medicines

Laura BrassLaura BrassBoard Member
Philip VickersPhilip VickersCEO
Robert TepperRobert TepperBoard Member
Cary PfefferCary PfefferBoard Member
Ron ValeRon ValeCo-Founder
J. Paul TaylorJ. Paul TaylorCo-Founder
Topica Pharmaceuticals
Topica Pharmaceuticals
Series C$58.5M112004Palo Alto, CA, US
Board Member· Board

Leadership at Topica Pharmaceuticals

Dr David E CohenDr David E CohenBoard Member
G. RaabG. RaabBoard Member

Similar to Topica Pharmaceuticals

HalluxHalluxLaguna Hills, CA, USPharmaceuticalsest. 2012HalluxLaguna Hills, CA, US · est. 2012

Hallux: Innovating safe, effective pharmaceutical solutions for common foot infections.

Series A · $18.7M14
Ansata TherapeuticsAnsata TherapeuticsSan Diego, CA, USTopical Drugsest. 2002Ansata TherapeuticsSan Diego, CA, US · est. 2002

Ansata Therapeutics Inc., a US-based biopharmaceutical company, specializes in developing topical drugs.

Series B · $2.5M30
Novelix PharmaceuticalsNovelix PharmaceuticalsLos Angeles, CA, USDermatology, Pharmaceuticalsest. 2005Novelix PharmaceuticalsLos Angeles, CA, US · est. 2005

Novelix Pharmaceuticals is a biotech firm focused on developing innovative dermatology products, including a promising topical drug for actinic keratosis.

Seed · $253.1k30
Verrica PharmaceuticalsVerrica PharmaceuticalsWest Chester, PA, USTopical Treatmentsest. 2013Verrica PharmaceuticalsWest Chester, PA, US · est. 2013

Verrica Pharmaceuticals: A clinical-stage company developing topical treatments for skin diseases in the US.

Public · $112.5M46
Johns Hopkins University
Johns Hopkins University
NonprofitNonprofit$186.5M19.5k1876Baltimore, MD, US
Board Member· Board

Recent news

A new startup from Figure’s founder is licensing NASA tech in a bid to curbnschool shootingsTechCrunch · 2024

Leadership at Johns Hopkins University

Thomas HaineThomas HaineBoard Member
Lou ForsterLou ForsterBoard Member
Paul RabilPaul RabilBoard Member
Ronald J. DanielsRonald J. DanielsBoard Member
Charlie ScharfCharlie ScharfBoard Member
Brian RogersBrian RogersBoard Member
Maze Therapeutics
Maze Therapeutics

South San Francisco, CA, US

Board Member· Board

Charles Homcy's Similar Executives & Operators

Nugroho HerucahyonoNugroho HerucahyonoCo-Founder · BukalapakLau Eng BoonLau Eng BoonBoard Member · BukalapakJay Geoffrey WacherJay Geoffrey WacherBoard Member · BukalapakSoemantri BrodjonegoroSoemantri BrodjonegoroBoard Member · BukalapakAchmad ZakyAchmad ZakyCo-Founder · BukalapakWILL WEI CHENGWILL WEI CHENGBoard Member · DiDiBo ZhangBo ZhangCo-Founder · DiDiDhirubhai H. AmbaniDhirubhai H. AmbaniBoard Member · Reliance Retail

People Similar to Charles Homcy

Jason ColomaJason ColomaBoard Member · BioAge LabsFaraz ZubairiFaraz ZubairiCEO · HumazeMDJason RhodesJason RhodesBoard Member · K36 TherapeuticsJoaquin BeltranJoaquin BeltranCEO at AwemazeMurad KarimiMurad KarimiCo-Founder · Epic KitchensJack BlaeserJack BlaeserBoard Member · Wedge